STAT3 Is Activated By DYRK1A and Is a Potential Therapeutic Target in B-ALL
Year: 2018
Type: conference-abstract
Source: Blood
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980425926
